These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20797455)

  • 21. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
    Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
    Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
    Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.
    Zhao H; Li HY; Han JF; Deng YQ; Li YX; Zhu SY; He YL; Qin ED; Chen R; Qin CF
    Appl Microbiol Biotechnol; 2013 Dec; 97(24):10445-52. PubMed ID: 24085395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.
    Liu CC; Lian WC; Butler M; Wu SC
    Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice.
    Meng T; Kolpe AB; Kiener TK; Chow VT; Kwang J
    PLoS One; 2011; 6(7):e21757. PubMed ID: 21747954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system.
    Pillay S; Meyers A; Williamson AL; Rybicki EP
    Biotechnol Prog; 2009; 25(4):1153-60. PubMed ID: 19572400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine.
    Maranga L; Rueda P; Antonis AF; Vela C; Langeveld JP; Casal JI; Carrondo MJ
    Appl Microbiol Biotechnol; 2002 Jun; 59(1):45-50. PubMed ID: 12073130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
    Pushko P; Tumpey TM; Bu F; Knell J; Robinson R; Smith G
    Vaccine; 2005 Dec; 23(50):5751-9. PubMed ID: 16143432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using a fed-batch culture strategy to enhance rAAV production in the baculovirus/insect cell system.
    Liu YK; Yang CJ; Liu CL; Shen CR; Shiau LD
    J Biosci Bioeng; 2010 Aug; 110(2):187-93. PubMed ID: 20547323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice.
    Dai W; Zhang C; Zhang X; Xiong P; Liu Q; Gong S; Geng L; Zhou D; Huang Z
    Vaccine; 2018 Jan; 36(5):653-659. PubMed ID: 29295756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An actively mixed mini-bioreactor for protein production from suspended animal cells.
    Diao J; Young L; Zhou P; Shuler ML
    Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
    Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process.
    Liu CC; Chang HW; Yang G; Chiang JR; Chow YH; Sai IH; Chang JY; Lin SC; Sia C; Hsiao CH; Chou AH; Chong P
    J Virol Methods; 2011 Sep; 176(1-2):60-8. PubMed ID: 21704080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus.
    Wang S; Fang L; Fan H; Jiang Y; Pan Y; Luo R; Zhao Q; Chen H; Xiao S
    Vaccine; 2007 Nov; 25(49):8220-7. PubMed ID: 17980465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TubeSpin bioreactor 50 for the high-density cultivation of Sf-9 insect cells in suspension.
    Xie Q; Michel PO; Baldi L; Hacker DL; Zhang X; Wurm FM
    Biotechnol Lett; 2011 May; 33(5):897-902. PubMed ID: 21267765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.
    Kondo K; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    J Med Virol; 2008 May; 80(5):841-6. PubMed ID: 18360909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.